- Home
- AWH
as 11-15-2024 4:00pm EST
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.
| Founded: | 1993 | Country: | United States |
| Employees: | N/A | City: | AUSTIN |
| Market Cap: | 13.5M | IPO Year: | N/A |
| Target Price: | $4.40 | AVG Volume (30 days): | 139.7K |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.43 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.72 - $5.65 | Next Earning Date: | 11-14-2024 |
| Revenue: | $8,923,000 | Revenue Growth: | -1.21% |
| Revenue Growth (this year): | 15.56% | Revenue Growth (next year): | 105.32% |
Latest Aspira Women's Health Inc. News
AWH Breaking Stock News: Dive into AWH Ticker-Specific Updates for Smart Investing
GuruFocus.com
3 days ago
Aspira Womens Health Inc (AWH) Q3 2024 Earnings Call Highlights: Strategic Wins Amidst Market ...
GlobeNewswire
4 days ago
Aspira Women’s Health Reports Selected Third Quarter 2024 Financial Results
GuruFocus.com
5 days ago
Aspira Women's Health Inc (AWH) Q3 2024 Earnings Report Preview: What to Expect
GlobeNewswire
11 days ago
Aspira Women’s Health Expands Co-Marketing and Distribution Collaboration with BioReference® to Include OvaWatch®
GlobeNewswire
14 days ago
Aspira Women’s Health to Announce Third Quarter Earnings Results and Host a Conference Call on Thursday, November 14, 2024
GlobeNewswire
24 days ago
Aspira Women’s Health Issues Letter to Shareholders and Announces Virtual Research & Development Day on October 29, 2024
GlobeNewswire
25 days ago
Aspira Women’s Health Selected to Receive $10 Million Award from ARPA-H’s Sprint for Women’s Health
GlobeNewswire
a month ago
Aspira Women’s Health Receives Approval from New York State Department of Health for OvaWatch®
Compare AWH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AWH Aspira Women's Health Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.